Translational bioinformatics: linking knowledge across biological and clinical realms

Center for Clinical and Translational Science, University of Vermont, Burlington, Vermont 05405, USA.
Journal of the American Medical Informatics Association (Impact Factor: 3.57). 07/2011; 18(4):354-7. DOI: 10.1136/amiajnl-2011-000245
Source: PubMed

ABSTRACT Nearly a decade since the completion of the first draft of the human genome, the biomedical community is positioned to usher in a new era of scientific inquiry that links fundamental biological insights with clinical knowledge. Accordingly, holistic approaches are needed to develop and assess hypotheses that incorporate genotypic, phenotypic, and environmental knowledge. This perspective presents translational bioinformatics as a discipline that builds on the successes of bioinformatics and health informatics for the study of complex diseases. The early successes of translational bioinformatics are indicative of the potential to achieve the promise of the Human Genome Project for gaining deeper insights to the genetic underpinnings of disease and progress toward the development of a new generation of therapies.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aims at designing a data model managing the vast majority of omic data types, dedicated to information retrieval on two dimensional levels, single patient and multi-patients. The exploitation of scientific health research data, in the search for new biomedical applications, is a promising challenge. Data integration gen- erated by scientific research, particularly omics, with clinical data stored in the Electronic Health Record (EHR) can lead to significant progress in the development of new diagnostic tests and therapies as well as improve our understanding of complex genetic diseases and cancers. Currently, a few solutions already exist such as i2b2 or Transmart. How- ever, they do not handle all main omic data types. Moreover, integrating omic analysis results in EHRs is today mandatory to help clinicians in decision making. This study proposes a generic omic data model dedicated to manag- ing main omic data types (expression data, DNA-methylation, variants, etc.), omic data representation, and information retrieval. Integrating omics data within clinical data involves: (i) identify the dif- ferent types of omic data, (ii) select relevant information in the context of integration with clinical data then (iii) design an effective omic data model. Four levels of data have been defined according to their level of interpre- tation. The second level representing interpreted data has been selected to build the data model. Various omic data types have been integrated into a database coupled to clinical data.
    Proceedings of the 2nd International Work-Conference on Bioinformatics and Biomedical Engineering, IWBBIO, 2014, Granada-Spain; 04/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Big data are receiving an increasing attention in biomedicine and healthcare. It is therefore important to understand the reason why big data are assuming a crucial role for the biomedical informatics community. The capability of handling big data is becoming an enabler to carry out unprecedented research studies and to implement new models of healthcare delivery. Therefore, it is first necessary to deeply understand the four elements that constitute big data, namely Volume, Variety, Velocity, and Veracity, and their meaning in practice. Then, it is mandatory to understand where big data are present, and where they can be beneficially collected. There are research fields, such as translational bioinformatics, which need to rely on big data technologies to withstand the shock wave of data that is generated every day. Other areas, ranging from epidemiology to clinical care, can benefit from the exploitation of the large amounts of data that are nowadays available, from personal monitoring to primary care. However, building big data-enabled systems carries on relevant implications in terms of reproducibility of research studies and management of privacy and data access; proper actions should be taken to deal with these issues. An interesting consequence of the big data scenario is the availability of new software, methods, and tools, such as map-reduce, cloud computing, and concept drift machine learning algorithms, which will not only contribute to big data research, but may be beneficial in many biomedical informatics applications. The way forward with the big data opportunity will require properly applied engineering principles to design studies and applications, to avoid preconceptions or over-enthusiasms, to fully exploit the available technologies, and to improve data processing and data management regulations.
    Yearbook of medical informatics 05/2014; 9(1). DOI:10.15265/IY-2014-0024
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The complex interaction of molecules within a biological system constitutes a functional module. These modules are then acted upon by both internal and external factors, such as genetic and environmental stresses, which under certain conditions can manifest as complex disease phenotypes. Recent advances in high-throughput biological analyses, in combination with improved computational methods for data enrichment, functional annotation, and network visualization, have enabled a much deeper understanding of the mechanisms underlying important biological processes by identifying functional modules that are temporally and spatially perturbed in the context of disease development. Systems biology approaches such as these have produced compelling observations that would be impossible to replicate using classical methodologies, with greater insights expected as both the technology and methods improve in the coming years. Here, we examine the use of systems biology and network analysis in the study of a wide range of rheumatic diseases to better understand the underlying molecular and clinical features.
    The Korean Journal of Internal Medicine 03/2015; 30(2):148-160. DOI:10.3904/kjim.2015.30.2.148


Available from